Avalo Therapeutics Inc.
(AVTX)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -31.54M | -41.66M | -84.38M | -63.50M | -16.07M | -40.05M | 11.87M | -16.47M | -10.49M | -16.06M | -13.05M | -10.49M |
| Depreciation & Amortization | 158.00K | 166.00K | 1.66M | 1.84M | 3.88M | 4.55M | 425.48K | 26.86K | 23.51K | 28.94K | 20.03K | 15.00K |
| Stock-Based Compensation | 3.48M | 7.55M | 8.17M | 6.79M | 2.53M | 2.43M | 1.16M | 1.69M | 394.75K | 1.09M | 748.65K | 588.13K |
| Other Working Capital | -8.61M | 4.18M | 961.00K | -3.88M | -5.24M | 9.18M | -113.00K | -245.03K | 1.20M | 325.07K | -174.13K | - |
| Other Non-Cash Items | 6.46M | 2.39M | 794.00K | 18.57M | -7.47M | 21.22M | 366.23K | 162.27K | 293.75K | 989.26K | 146.93K | 1.19M |
| Deferred Income Tax | 14.00K | 28.00K | 22.00K | 195.59K | 16.74K | -16.75K | -832.63K | -72.63K | -1.31M | -1.18M | - | - |
| Change in Working Capital | -9.24M | 4.77M | 2.84M | -4.44M | -2.03M | 8.73M | -466.75K | 87.07K | 927.77K | -383.29K | 644.26K | - |
| Operating Cash Flow | -30.68M | -26.75M | -70.89M | -40.54M | -19.13M | -3.13M | 12.52M | -14.57M | -10.16M | -15.52M | -11.49M | -9.29M |
| Capital Expenditures | -158.00K | -95.00K | -113.00K | -62.66K | -262.01K | -564.41K | -23.32K | -34.88K | -19.98K | -19.50K | -29.27K | -12.43K |
| Acquisitions | - | - | - | 11.19M | 3.96M | 1.43M | -18.89M | - | - | - | - | - |
| Purchase of Investments | - | - | - | -11,194.90B | - | - | - | - | - | - | - | - |
| Sales Maturities Of Investments | - | - | - | 12,836.70B | - | - | - | - | - | - | - | - |
| Other Investing Acitivies | 25.00K | - | - | -1,641.80B | -4.14M | -1K | - | - | - | - | - | - |
| Investing Cash Flow | -133.00K | -95.00K | -113.00K | 11.13M | -443.00K | 865.46K | -18.91M | -34.88K | -19.98K | -19.50K | -29.27K | -12.43K |
| Debt Repayment | -21.24M | - | 32.90M | - | -256.14K | - | -2.37M | -3.31M | -1.81M | 9.64M | - | - |
| Common Stock Repurchased | - | -14.81M | - | - | -33.96K | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 67.00K | -14.70M | 1.93M | 332.54K | 131.07K | 6.55M | -232.38K | -114.94K | -2.27M | 14.22M | 5.42M | 17.71M |
| Financial Cash Flow | 25.04M | -14.70M | 106.76M | 44.78M | 12.56M | 10.40M | 3.74M | -1.43M | 19.60M | 23.86M | 5.42M | 17.71M |
| Net Cash Flow | -5.77M | -41.55M | 35.76M | 15.38M | -7.02M | 8.14M | -2.66M | -16.03M | 9.42M | 8.32M | -6.10M | 8.41M |
| Free Cash Flow | -30.84M | -26.85M | -71.00M | -40.60M | -19.40M | -3.69M | 12.50M | -14.61M | -10.18M | -15.54M | -11.51M | -9.30M |